...
【24h】

Mixed chimerism [Review]

机译:混合嵌合体[评论]

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Induction of mixed chimerism has the potential to overcome the current limitations of transplantation, namely chronic rejection, complications of immunosuppressive e therapy and the need for xenografts to overcome the current shortage of allogeneic organs. Successful achievement of mixed chimerism had been shown to tolerize T cells, B cells and possibly natural killer cells, the lymphocyte subsets that pose major barriers to allogeneic and xenogeneic transplants. Current understanding of tile mechanisms involved in tolerization of each cell type is reviewed. Considerable advances have bet II made in reducing the potential toxicity of conditioning regimens required for the induction of mixed chimerism in rodent models, and translation of these strategies to large animal models and in a patient are important advances toward more widespread clinical application of the mixed chimerism approach for tolerance induction. [References: 194]
机译:混合嵌合体的诱导有可能克服目前移植的局限性,即慢性排斥,免疫抑制性电子疗法的并发症以及需要异种移植来克服目前同种异体器官的短缺。混合嵌合体的成功实现已显示出可以耐受T细胞,B细胞以及可能的自然杀伤细胞,这些淋巴细胞亚群构成了同种异体和异种移植的主要障碍。综述了目前对每种细胞类型的耐受性涉及的机制的了解。在降低啮齿动物模型中诱导混合嵌合体所需的条件疗法的潜在毒性方面,赌注II已经取得了相当大的进步,并且将这些策略转化为大型动物模型和患者的方法是朝着更广泛的临床应用的方向发展的重要进步。公差诱导的方法。 [参考:194]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号